Status:
COMPLETED
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Herpes Zoster
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the investigational zoster vaccine, is generally well tolerated when administered to participants with a history of herpes zoster.
Eligibility Criteria
Inclusion
- Adults ≥ 50 years of age with a history of herpes zoster ≥ 5 years prior to enrollment
Exclusion
- History of allergy to any vaccine component
- Prior receipt of a varicella or zoster vaccine
- Ability to defend against infection is suppressed by a medical condition or medication
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00322231
Start Date
May 1 2006
End Date
July 1 2007
Last Update
January 26 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.